复星医药(600196.SH)：拟推2025年A股股票期权激励计划

Group 1 - The core point of the news is that Fosun Pharma has announced a stock option incentive plan for 2025, which allows for the granting of up to 5,726,100 A-share options [1] - The total number of A-shares corresponding to the options is also 5,726,100, representing approximately 0.2144% of the company's total shares and 0.2729% of the total A-shares excluding treasury shares [1]